Morepen Laboratories Ltd. (MOREPENLAB): Morepen Laboratories Share Price hits fresh 52-week high; stock rises 3.38%

Morepen Laboratories Share Price rose to Rs 109.80, up 3.38% from the previous close of Rs 106.21, and set a fresh 52-week high of Rs 109.88. The company’s market capitalisation stands at Rs 5,819.82 crore. This Morepen Laboratories Share Price update confirms a new yearly high in today’s session, while the supplied data does not establish a company-specific catalyst. Univest is tracking the move as part of its Morepen Laboratories Stock News coverage.

The stock opened at Rs 106.25 and traded between Rs 101.57 and Rs 109.88 during the day. Turnover stood at Rs 13.86 crore. On the supplied data, the price event is clear: Morepen Laboratories Share Price is trading close to its fresh 52-week peak and has moved above the previous close by Rs 3.59. For readers following Morepen Laboratories Share Price Today, the key question is not only the day’s change but also how the current valuation and healthcare-sector comparisons fit around this one-year high.

Within the first look at Morepen Laboratories Stock News, the main verified numbers are the current price, the yearly high, market capitalisation, P/E of 41.41, P/B of 4.47, ROE of 11.78, ROCE of 15.48, EPS of 2.56 and dividend yield of 0.19%. Univest notes that the event is price-led and fact-based: the stock has reached a fresh 52-week high, but the supplied dataset does not identify a company announcement, earnings release or other specific trigger. Investors tracking Morepen Laboratories Share Price Live will therefore need to watch how the stock behaves around this level and how its fundamentals compare with peers in the Pharmaceuticals & Drugs space.

Morepen Laboratories Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 109.8
Previous Close	Rs 106.21
Today's Move	+Rs 3.59 (+3.38%)
Open	Rs 106.25
High	Rs 109.88
Low	Rs 101.57
Turnover	Rs 13.86 crore
Market Capitalisation	Rs 5,819.82 crore

Morepen Laboratories Ltd. (MOREPENLAB) traded at Rs 109.8 versus the previous close of Rs 106.21, a rise of 3.38%. The stock opened at Rs 106.25, reached a high of Rs 109.88 and touched a low of Rs 101.57.

Morepen Laboratories Share Price Today shows a clear session-level rise from Rs 106.21 to Rs 109.80, an increase of Rs 3.59 or 3.38%. The stock opened at Rs 106.25, moved to an intraday low of Rs 101.57 and reached a day high of Rs 109.88, which also matches the fresh 52-week high. That makes today’s session important for Morepen Laboratories Share Price because the stock ended close to its peak after trading through a wide intraday range. Univest treats this as a factual price event rather than a comment on the reason behind it.

For readers searching Morepen Laboratories Share Price News, the important comparison is the relationship between the current price and the previous close. The move of Rs 3.59 is straightforward to verify, and the day’s high of Rs 109.88 sits only marginally above the closing level of Rs 109.80. Turnover of Rs 13.86 crore provides a monetary measure of activity during the session, but it should be read simply as traded value, not as a signal of cause or participation. Morepen Laboratories Share Price Today is therefore defined by a new yearly high, a positive close and a session that stayed near the top of the day’s range.

From a market-news angle, Morepen Laboratories Share Price is appearing in Stocks in News and 52 Week High Stocks discussions because the price has established a fresh 52-week peak. The event is relevant for Morepen Laboratories Share Price Update tracking, but the supplied data alone does not explain why the stock moved to this level. Univest therefore frames the move as a confirmed price milestone, with further analysis resting on fundamentals and sector comparisons rather than unsupported assumptions.

Morepen Laboratories Ltd. (MOREPENLAB) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 5,819.82 crore
P/E Ratio	41.41x
P/B Ratio	4.47x
ROE	11.78%
ROCE	15.48%
EPS	Rs 2.56
Book Value Per Share	Rs 23.78
Dividend Yield	0.19%

Morepen Laboratories Ltd. (MOREPENLAB) fundamental metrics show P/E 41.41x, P/B 4.47x, ROE 11.78%, ROCE 15.48%. These figures provide context only and are not a buy or sell signal.

Morepen Laboratories Ltd. has a market capitalisation of Rs 5819.82 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 41.41x, P/B at 4.47x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 11.78% and ROCE of 15.48%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 2.56, book value per share of Rs 23.78, dividend yield of 0.19%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 31.12x, median ROE of 11.78%, median ROCE of 13.59%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	41.41x
Benchmark Median P/E	31.12x
Benchmark Average P/E	48.14x
Benchmark P/E Range	3.7x to 672.45x
Company P/B Ratio	4.47x
Benchmark Median P/B	2.87x
Company ROE	11.78%
Benchmark Median ROE	11.78%
Company ROCE	15.48%
Benchmark Median ROCE	13.59%
Company Market Capitalisation	Rs 5,819.82 crore
Benchmark Median Market Cap	Rs 630.79 crore

Morepen Laboratories Ltd. (MOREPENLAB) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Morepen Laboratories Ltd. (MOREPENLAB) has a P/E ratio of 41.41x, which is above the benchmark median of 31.12x, a difference of +33.07%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Morepen Laboratories Ltd. (MOREPENLAB) has a ROE of 11.78%, which is equal to the benchmark median of 11.78%, a difference of 0%. Morepen Laboratories Ltd. (MOREPENLAB) has a ROCE of 15.48%, which is above the benchmark median of 13.59%, a difference of +13.91%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Orchid Pharma Ltd.	ORCHPHARMA	5,827.43	672.45	4.48	7.86	8.05
IOL Chemicals And Pharmaceuticals Ltd.	IOLCP	5,717.92	34.01	3.07	7.9	10.65
Innova Captab Ltd.	INNOVACAP	6,036.37	38.62	5.32	13.75	15.04
FDC Ltd.	FDC	5,569.73	19.04	2.13	12.19	16.52
Bliss GVS Pharma Ltd.	BLISSGVS	6,238.89	45.81	5.06	12.11	17.4

Morepen Laboratories Ltd. (MOREPENLAB) has a P/E ratio of 41.41x compared with the displayed peer median of 38.62x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 11.78% compares with a peer median of 12.11% across the companies shown in the table. ROCE stood at 15.48% versus the displayed peer median of 15.04%, providing a capital-efficiency comparison. Morepen Laboratories Ltd. (MOREPENLAB) has a market capitalisation of Rs 5,819.82 crore. Among the 5 peers shown, 3 have a larger market capitalisation.

Why Investors Are Watching Morepen Laboratories

• Morepen Laboratories Share Price hit a fresh 52-week high of Rs 109.88 and closed at Rs 109.80.
• Morepen Laboratories Share Price Today is up Rs 3.59, or 3.38%, versus the previous close of Rs 106.21.
• Morepen Laboratories Share Price carries a market capitalisation of Rs 5,819.82 crore.
• Morepen Laboratories Fundamental Analysis shows P/E of 41.41, P/B of 4.47, ROE of 11.78 and ROCE of 15.48.
• Morepen Laboratories Share Price sits in the Healthcare sector and Pharmaceuticals & Drugs industry with peer and benchmark comparisons available.

About Morepen Laboratories

Morepen Laboratories Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied dataset identifies the company through its listed market data, sector classification and financial metrics rather than a long business-description note. For Morepen Laboratories Share Price readers, the important verified context is that the company is part of a 202-company same-industry benchmark and a 288-company same-sector set.

Univest uses that classification to frame Morepen Laboratories Stock News and Morepen Laboratories Company News in a consistent market context. The company’s financial indicators, market capitalisation and peer set provide the main public reference points available in this article, and they are enough to support a factual Morepen Laboratories Share Price Update.

Track Morepen Laboratories Share Price on Univest

Use Morepen Laboratories Ltd. (MOREPENLAB) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Track Morepen Laboratories Share Price on Univest for live updates, fundamental ratios, shareholding pattern, 52-week levels and market insights. Univest combines Morepen Laboratories Share Price Today with structured company data so readers can review the stock in one place.

For Morepen Laboratories Stock Analysis and Morepen Laboratories Latest News, Univest also places the share price alongside sector benchmarks, peer metrics and financial indicators. That makes it easier to follow Morepen Laboratories Share Price Live without switching between multiple market pages.

Frequently Asked Questions

Why is Morepen Laboratories Share Price in the news today?

Ans. Morepen Laboratories Share Price is in focus because it touched a fresh 52-week high of Rs 109.88 and closed at Rs 109.80. The move is backed by a 3.38% rise from the previous close of Rs 106.21.

What is the current Morepen Laboratories Share Price today?

Ans. The current Morepen Laboratories Share Price is Rs 109.80. It is higher than the previous close of Rs 106.21 and sits just below the day’s high of Rs 109.88, which is also the fresh 52-week high.

What is the market capitalisation of Morepen Laboratories?

Ans. Morepen Laboratories has a market capitalisation of Rs 5,819.82 crore. In the supplied healthcare benchmark, that is above the median market cap of Rs 630.79 crore and below the average of Rs 14,081.22 crore.

What does the Morepen Laboratories 52-week high show?

Ans. The 52-week high shows that Morepen Laboratories Share Price reached Rs 109.88 during the session. It is a yearly high, but the supplied data does not establish any specific company event as the reason.

Is Morepen Laboratories Share Price expensive on valuation?

Ans. Morepen Laboratories Share Price has a P/E of 41.41 and a P/B of 4.47. Those are above the supplied industry medians of 31.12 and 2.87, while ROE and ROCE remain above or near benchmark levels.

How do Morepen Laboratories fundamentals look?

Ans. Morepen Laboratories reports EPS of 2.56, book value of Rs 23.78 and dividend yield of 0.19%. Revenue and net profit also rose in the Jun 2026 quarter compared with Jun 2025, adding factual context to the move.